Delamanid for Multidrug-Resistant Pulmonary Tuberculosis-Reference-Cited by-同舟云学术

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

Published:2012-06-07 Issue:23 Volume:366 Page:2151-2160
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Gler Maria Tarcela,Skripconoka Vija,Sanchez-Garavito Epifanio,Xiao Heping,Cabrera-Rivero Jose L.,Vargas-Vasquez Dante E.,Gao Mengqiu,Awad Mohamed,Park Seung-Kyu,Shim Tae Sun,Suh Gee Young,Danilovits Manfred,Ogata Hideo,Kurve Anu,Chang Joon,Suzuki Katsuhiro,Tupasi Thelma,Koh Won-Jung,Seaworth Barbara,Geiter Lawrence J.,Wells Charles D.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1112433

Cited by 670 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. Delamanid proliposomal powder aerosols targeting alveolar macrophages for treatment of pulmonary extensively drug-resistant tuberculosis treatment: Bioactivity, biocompatibility, and structure elucidation;Journal of Drug Delivery Science and Technology;2024-10

3. Therapeutic drug monitoring in tuberculosis;European Journal of Clinical Pharmacology;2024-09-06

4. Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasets;The International Journal of Tuberculosis and Lung Disease;2024-09-01

5. Candidate anti-tuberculosis medicines and regimens under clinical evaluation;Clinical Microbiology and Infection;2024-09